Home > Healthcare > Medical Devices > Therapeutic Devices > End Stage Renal Disease Market
End Stage Renal Disease Market Size
- Report ID: GMI6256
- Published Date: Jul 2023
- Report Format: PDF
End Stage Renal Disease Market Size
End stage renal disease market was valued at around USD 114 billion in 2022 and is projected to reach over USD 183.9 billion by 2032. This incremental growth rate is owing to increasing prevalence of diabetes and hypertension coupled with rising number of patients suffering from end stage renal diseases (ESRD).
Aging population and growing demand for dialysis associated with technological advancement in diagnostic and treatment devices is anticipated to drive the market growth. Factors such as increasing prevalence of chronic kidney disease (CKD), rising awareness for early diagnosis of ESRD, and improving access to healthcare in developing regions is expected to further fuel the industry expansion.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| End Stage Renal Disease Market Size in 2022: | USD 114 billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5% |
| 2032 Value Projection: | USD 183.9 billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 160 |
| Tables, Charts & Figures: | 347 |
| Segments covered: | Treatment, Diagnosis, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Rising prevalence of diabetes, hypertension, obesity, and cardiovascular diseases contribute to increasing ESRD patient population. Technological advancements in diagnosis and treatment devices have led to improved treatment efficiency, patient comfort, and infection control measures. Emerging economies are witnessing growth due to increased awareness, improving healthcare infrastructure, and expanding reimbursement coverage. Major players in the market are emphasizing on research and development activities, strategic partnerships, and product innovation to maintain a competitive edge. Therefore, the end stage renal disease industry is witnessing substantial growth and innovation, driven by the demand for better diagnosis and treatment of chronic ailments and technological advancements in end stage renal disease treatment devices.
End-stage renal disease (ESRD) is a chronic diseases that indicates the final stage of chronic kidney disease (CKD) where the kidneys can no longer function adequately to sustain life. Patients suffering from ESRD require renal replacement therapy (RRT), that includes options such as kidney transplantation and dialysis treatments.
However, high cost associated with advance dialysis instruments can pose a significant challenge and impede the market growth in the coming years. Dialysis equipment, such as hemodialysis machines, peritoneal dialysis equipment, and related supplies, can be expensive to procure and maintain. For instance, the cost of hemodialysis machine can range between USD 10,000 to over USD 45,000 and can vary according to the advancements and technology installed. This high costs can place a significant financial burden on healthcare systems, especially in countries with limited healthcare budget. This financial strain can affect the availability and accessibility of dialysis treatments, thereby impacting the growth of the ESRD market.
The high capital investment required for equipment purchase, installation, maintenance, and regular upgrades can affect the financial viability of these providers. This financial burden limits the ability to expand their services, invest in new technologies, and offer competitive pricing. This, in turn, can impact the availability and quality of dialysis services in the market. Thus, the aforementioned factors are anticipated to impede the market progress.
Frequently Asked Questions (FAQ) :
End Stage Renal Disease Market Scope
